Spero Therapeutics, Inc. ( SPRO) - Key Metrics
SPRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.16 | -$0.09 | -$0.09 |
| 2026Q1 | $0 | -$0.13 | $0.28 | $0.28 |
| 2025Q4 | $0.71 | $0.56 | -$0.15 | -$0.15 |
| 2025Q3 | $0.05 | -$0.13 | $0.31 | $0.31 |
| 2025Q2 | $0.21 | -$0.03 | -$0.32 | -$0.32 |
SPRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.45 |
| 2026Q1 | 0% | -4.50 |
| 2025Q4 | 0% | 1.04 |
| 2025Q3 | 0% | -3.62 |
| 2025Q2 | 0% | -23.93 |
SPRO
Price: $1.20
52 week price:
Earnings Per Share: 0.28 USD
P/E Ratio: 4.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179389
Market Capitalization: 72.2 million